Brian C.  Evanko net worth and biography

Brian Evanko Biography and Net Worth

Brian Evanko serves as the Executive Vice President and Chief Financial Officer (CFO) of The Cigna GroupSM. As CFO, Evanko has executive leadership responsibility for the financial operations and functions, enterprise strategy, and Investment Management and Underwriting units for The Cigna Group. Since assuming this role in January 2021, the company has delivered against its Adjusted Earnings per Share (EPS) objectives and further refined its long-term roadmap for success. He is a member of the Enterprise Leadership Team for The Cigna Group.

Previously, Evanko led Cigna HealthcareSM U.S. Government business, which included Medicare Advantage, Government Pharmacy, Medicaid, Individual and Family Plans (IFP), and Cigna Supplemental Benefits (CSB). Under Evanko’s leadership, the company's Medicare Advantage business experienced historic addressable market expansion and growth—as well as drove quality care and outstanding customer service, positioning the business for long-term success in a highly dynamic regulatory environment.

Evanko also previously served as the President of U.S. Individual and Voluntary businesses for Cigna Healthcare, where he led the implementation of the Affordable Care Act (ACA) for IFP, and subsequently positioned the business for long-term profitable growth.

Evanko joined the company's Finance organization in 1998 and has served in a number of roles, including Business Financial Officer for Global Individual Health, Life, and Accident operations based in Hong Kong and Singapore from 2009 to 2013. He also held various roles across the company's U.S. and International businesses in Hartford, Connecticut and Philadelphia, Pennsylvania.

Evanko earned a bachelor’s degree in actuarial science from Pennsylvania State University and holds the FSA (Fellow of the Society of Actuaries), MAAA (Member of the American Academy of Actuaries) and CFA (Chartered Financial Analyst) designations. He serves on the National Board of Directors for Back on My Feet, a national organization operating in 13 major cities across the U.S. that combats homelessness through the power of running, community support, and essential employment and housing resources. Evanko also serves on the Executive Committee of the Connecticut Science Center, the state’s foremost institution focused on lifelong learning through science. A marathon runner, Evanko has been instrumental in the partnership between The Cigna Group and Achilles International and has served as a race guide for runners with disabilities at the Walt Disney World® and Marine Corps Marathons.

What is Brian C. Evanko's net worth?

The estimated net worth of Brian C. Evanko is at least $11.11 million as of August 2nd, 2023. Mr. Evanko owns 31,332 shares of The Cigna Group stock worth more than $11,106,254 as of April 27th. This net worth approximation does not reflect any other investments that Mr. Evanko may own. Additionally, Mr. Evanko receives an annual salary of $2,630,000.00 as CFO at The Cigna Group. Learn More about Brian C. Evanko's net worth.

How old is Brian C. Evanko?

Mr. Evanko is currently 47 years old. There are 5 older executives and no younger executives at The Cigna Group. The oldest executive at The Cigna Group is Mr. David Michael Cordani, President, CEO & Chair of the Board, who is 59 years old. Learn More on Brian C. Evanko's age.

What is Brian C. Evanko's salary?

As the CFO of The Cigna Group, Mr. Evanko earns $2,630,000.00 per year. There are 2 executives that earn more than Mr. Evanko. The highest earning executive at The Cigna Group is Mr. David Michael Cordani, President, CEO & Chair of the Board, who commands a salary of $5,110,000.00 per year. Learn More on Brian C. Evanko's salary.

How do I contact Brian C. Evanko?

The corporate mailing address for Mr. Evanko and other The Cigna Group executives is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The Cigna Group can also be reached via phone at (860) 226-6000 and via email at [email protected]. Learn More on Brian C. Evanko's contact information.

Has Brian C. Evanko been buying or selling shares of The Cigna Group?

Brian C. Evanko has not been actively trading shares of The Cigna Group during the last ninety days. Most recently, Brian C. Evanko sold 2,307 shares of the business's stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $300.00, for a transaction totalling $692,100.00. Following the completion of the sale, the chief financial officer now directly owns 31,332 shares of the company's stock, valued at $9,399,600. Learn More on Brian C. Evanko's trading history.

Who are The Cigna Group's active insiders?

The Cigna Group's insider roster includes Mary Agolglia Hoeltzel (VP), Lisa Bacus (EVP), David Cordani (CEO), Brian Evanko (Exec. VP & CFO ), Brian Evanko (CFO), Eric Foss (Director), Elder Granger (Director), Isaiah Harris, Jr. (Chairman), Mary Hoeltzel (CAO), Nicole Jones (EVP), Matthew Manders (Insider), Thomas McCarthy (CFO), Steven Miller (EVP), Alan Muney (EVP), John Murabito (EVP), Everett Neville (EVP), Eric Palmer (CFO), John Partridge (Director), William Roper (Director), Cynthia Ryan (EVP), Jason Sadler (Insider), Paul Sanford (EVP), Michael Triplett (Insider), Timothy Wentworth (CEO), and Donna Zarcone (Director). Learn More on The Cigna Group's active insiders.

Are insiders buying or selling shares of The Cigna Group?

During the last year, insiders at the health services provider sold shares 18 times. They sold a total of 154,668 shares worth more than $50,986,538.23. The most recent insider tranaction occured on March, 25th when CEO David Cordani sold 31,209 shares worth more than $11,084,500.53. Insiders at The Cigna Group own 0.6% of the company. Learn More about insider trades at The Cigna Group.

Information on this page was last updated on 3/25/2024.

Brian C. Evanko Insider Trading History at The Cigna Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/2/2023Sell2,307$300.00$692,100.0031,332View SEC Filing Icon  
3/11/2019Buy2,000$163.40$326,800.00View SEC Filing Icon  
See Full Table

Brian C. Evanko Buying and Selling Activity at The Cigna Group

This chart shows Brian C Evanko's buying and selling at The Cigna Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

The Cigna Group Company Overview

The Cigna Group logo
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Read More

Today's Range

Now: $354.47
Low: $351.42
High: $355.15

50 Day Range

MA: $349.88
Low: $332.70
High: $364.08

2 Week Range

Now: $354.47
Low: $240.50
High: $365.71

Volume

830,527 shs

Average Volume

1,260,787 shs

Market Capitalization

$103.63 billion

P/E Ratio

20.38

Dividend Yield

1.58%

Beta

0.56